Study of REM-422 in Patients With AML or Higher Risk MDS
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Remix Therapeutics
Related studies linked through entity extraction aliases.
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2